Roche CEO points to higher future drug prices in Switzerland after US deal

Core Insights - Deals between pharmaceutical companies and the U.S. government aimed at reducing drug prices are expected to increase the cost of new drugs in Switzerland, according to the CEO of Roche [1] Group 1: Impact on Drug Pricing - The agreements in the U.S. to lower medicine prices may lead to higher costs for new pharmaceuticals in Switzerland [1]